| 000 | 01902 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250515171042.0 | ||
| 264 | 0 | _c20091013 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/j.1476-5381.2009.00232.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoroni, F | |
| 245 | 0 | 0 |
_aSelective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cJul 2009 |
||
| 300 |
_a854-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 | _aCell Hypoxia |
| 650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlucose _xdeficiency |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitosis _xdrug effects |
| 650 | 0 | 4 | _aNecrosis |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aOxygen _xmetabolism |
| 650 | 0 | 4 | _aPoly(ADP-ribose) Polymerase Inhibitors |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
| 650 | 0 | 4 |
_aPyramidal Cells _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Culture Techniques |
| 700 | 1 | _aFormentini, L | |
| 700 | 1 | _aGerace, E | |
| 700 | 1 | _aCamaioni, E | |
| 700 | 1 | _aPellegrini-Giampietro, D E | |
| 700 | 1 | _aChiarugi, A | |
| 700 | 1 | _aPellicciari, R | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 157 _gno. 5 _gp. 854-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.2009.00232.x _zAvailable from publisher's website |
| 999 |
_c18850916 _d18850916 |
||